The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

Share Price Information for Mobeus I&g (MIX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.00
Bid: 54.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.505%)
Open: 56.00
High: 56.00
Low: 56.00
Prev. Close: 56.00
MIX Live PriceLast checked at -
Mobeus Income & Growth VCT is an Investment Trust

To provide investors with a regular income stream, by way of tax-free dividends, generated from income and capital returns, while continuing at all times to qualify as a VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

10 Nov 2023 13:30

RNS Number : 1304T
Mobeus Income & Growth VCT PLC
10 November 2023
 

MOBEUS INCOME & GROWTH VCT PLC

("the Company")

LEI: 213800HKOSEVWS7YPH79

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2023

 

Mobeus Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 September 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30 September 2023

(unaudited)

At 30 June 2023

(unaudited)

Net assets attributable to shareholders

£102.94 million

£100.15 million

Shares in issue

165,644,278

156,718,602

Net asset value (NAV) per share

62.15 pence

60.12 pence

Cumulative dividends paid

161.80 pence

161.80 pence

Cumulative Total return (net asset value basis) per share since inception

223.95 pence

221.92 pence

 

The NAV per share has increased by 2.03 pence in the quarter (an increase of 3.4% from the NAV per share at 30 June 2023).

 

INVESTMENT ACTIVITY DURING THE PERIOD

New Investment during the period

On 26 July 2023, the Company completed a new investment of £0.49 million into Mable Therapy Limited, a digital health platform for speech therapy and counselling for children and young adults.

 

On 3 August 2023, the Company completed a new investment of £0.48 million into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.

 

Further Investments during the period

On 4 July 2023, a follow on equity investment of £0.41 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.

 

On 11 August 2023, a follow on loan investment of £0.15 million was made into Orri Limited, an intensive day care provider for adults with eating disorders.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

There has been no activity post-quarter.

 

SHARE BUYBACK DURING THE PERIOD

On 26 September 2023, the Company purchased 946,163 of its own ordinary shares at a price of 57.11 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

DIVIDEND DECLARED DURING THE PERIOD

On 21 September 2023, a second interim dividend of 4.50 pence per share in respect of the year ending 31 December 2023 was declared and was paid on 8 November 2023 to all Shareholders whose names were on the register on 29 September 2023. Payment of this interim dividend will reduce NAV per share (shown above) to 57.65 pence and increase cumulative dividends paid to 166.30 pence per share.

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFMFDSEDSEFF
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSDividend Declaration
15th Apr 20247:00 amRNSAnnual Financial Report
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
22nd Feb 202411:00 amRNSNet Asset Value(s)
1st Feb 202411:46 amRNSVoting Rights and Capital
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202312:00 pmRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
27th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20231:30 pmRNSInterim Management Statement
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20231:00 pmRNSTransaction in Own Shares
21st Sep 202310:15 amRNSDividend Declaration
18th Sep 20231:00 pmRNSHalf-year Report
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:00 pmRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20237:00 amRNSResult of AGM
23rd May 20237:00 amRNSInterim Management Statement
2nd May 202310:00 amRNSTotal Voting Rights
19th Apr 202310:00 amRNSTransaction in Own Shares
13th Apr 20231:00 pmRNSDividend Declaration
4th Apr 20236:07 pmRNSAnnual Financial Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
1st Mar 20237:00 amRNSTotal Voting Rights
6th Feb 20236:20 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:06 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
17th Jan 20235:16 pmRNSDirector Declaration
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
22nd Dec 20229:34 amRNSTransaction in Own Shares
5th Dec 20225:49 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited
28th Nov 20228:34 amRNSTransaction in Own Shares and total voting rights
17th Nov 20227:00 amRNSDirector/PDMR Shareholding
16th Nov 20225:41 pmRNSIssue of Equity and Total Voting Rights
9th Nov 20223:40 pmRNSNet Asset Value(s)
9th Nov 20223:00 pmRNSInterim Management Statement
17th Oct 20221:52 pmRNSOffer for Subscription – Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.